We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Pocket-Sized Zinc Deficiency Test Evaluated

By LabMedica International staff writers
Posted on 09 Oct 2019
Print article
Image: Scientists have developed a test that detects deadly zinc deficiencies in a single drop of the blood. The test could be made compact enough so that many fit in an aid worker’s pocket. It could help expose broad malnutrition in crisis regions (Photo courtesy of Georgia Institute of Technology).
Image: Scientists have developed a test that detects deadly zinc deficiencies in a single drop of the blood. The test could be made compact enough so that many fit in an aid worker’s pocket. It could help expose broad malnutrition in crisis regions (Photo courtesy of Georgia Institute of Technology).
Easy-to-perform, relatively inexpensive blood diagnostics have transformed at-home healthcare for some patients, but they require analytical equipment and are not easily adapted to measuring other biomarkers.

The requirement for reliable quantification in complex sample types, such as blood, has been a critical roadblock in developing and deploying inexpensive, minimal-equipment diagnostics. A pocket-sized zinc deficiency test has been developed that could be taken to remote regions where masses are malnourished with no complex transport or preservation necessary.

A team of scientists working with the Georgia Institute of Technology (Atlanta, GA, USA) developed a platform for inexpensive, easy-to-use diagnostics that uses cell-free expression to generate colored readouts that are visible to the naked eye, yet quantitative and robust to the interference effects seen in complex samples. The platform includes plasmids, which are loops of DNA. They are not the same DNA strands behind reproduction and cell construction, but function instead like nano-organs with genetic programs that normally guide bacterial cell processes. The team engineered their own plasmids to direct other parts extracted from bacteria to make the blood test work.

The test uses a signal molecule that is partly a big sugar and starts out yellow, but once the plasmid makes an enzyme that cleaves the sugar, the molecule turns purple. Zinc levels regulate how much enzyme is made more zinc means more enzyme and more purple. If the test remains yellow, zinc is perilously low. The new technology showed high potential as a basis for an inexpensive, easy malnutrition test for use in the field that could be expanded to include many vital nutrients and other health indicators.

The new test is freeze-dried to a powder that is kept at room temperatures, could be read in the field, and may be suitable for precise analysis with an applicable smartphone app. It could overcome the clinical and logistical travails of other tests, including refrigerated transport to the field or back to a laboratory, as well as lost time. The test not only detects zinc, but also quantifies its clinically relevant levels, which is necessary to detect malnourishment and is one of the new test's main innovations. Aid agencies could use a field version of the test to get immediate information to quickly influence policy decisions on nutritional interventions.

Mark P. Styczynski, PhD, an associate professor and first author of the study, said, “In the developing world today, many people may get enough calories but miss out on a lot of nutrients. You can look at someone and tell if they're getting enough calories but not if they're getting sufficient amounts of developmentally important nutrients. The impact is greatest on pregnant mothers, as well as children under the age of 5, which is when they have the highest mortality.” The study was published on September 4, 2019, in the journal Science Advances.

Related Links:
Georgia Institute of Technology

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.